AACR 2025 preview – new preclincal approaches abound
Novel targets including Ly6E and LRRC15 feature alongside more popular mechanisms.
Novel targets including Ly6E and LRRC15 feature alongside more popular mechanisms.
Meanwhile, Torl BioTherapeutics appears to be catching up with BioNTech.